2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.65+$0.03 (+2.17%)
Price as of Jul 13, 2026 7:41 PM EDT- $361.2MMarket Cap
- -56.37%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.65+$0.03 (+2.17%)
PROK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.61 | ||
Change | -$0.15 (-8.52%) | ||
Open | $1.75 | ||
High | $1.75 | ||
Low | $1.60 | ||
Previous Close | $1.76 | ||
Volume | 2,048,282 | ||
30-Day Average Volume | 1,620,852 | ||
1-Week Change | -19.10% | ||
1-Month Change | -1.83% | ||
1-Year Change | -56.37% | ||
3-Year Change | -85.66% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 205.2M | ||
Total Assets | $292.8M | ||
Market Cap | $361.2M | ||
Enterprise Value | $259.3M | ||
Period: QTR TTM FY | |||
Revenue | $226,000.00 | ||
Net Income | -$20.0M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$20.0M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $209.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 1,147 | ||
P/B | -0 | ||
P/E | -13 | ||
PEG | 5 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue